ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

An AI-generated drug, rentosertib from Insilico Medicine, reduced biological age markers in a 42-patient trial over 12 weeks. The study in Nature Biotechnology used six aging clocks, while placebo patients saw no change. The drug still requires many trials before regulatory approval.
Tap to vote and see what everyone thinks.
Summary by ByteBrief